[ABCL] QoQ Quarter Result on 31-Dec-2022 [#Q4]

Stock
[ABCL] AbCellera Biologics Inc.
Announcement Date
21-Feb-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- -212.28%
YoY- -149.86%
Quarter Report
ABCL's Result
ABCL's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Revenue 6,599 10,056 12,192 21,545 101,383 45,917 316,581 -92.40%
PBT -39,276 -38,004 -48,148 -31,412 46,587 -6,886 230,809 -
Tax -10,666 -7,476 -8,038 -1,519 19,963 -101 62,236 -
NP -28,610 -30,528 -40,110 -29,893 26,624 -6,785 168,573 -
Tax Rate - - - - -42.85% - -26.96% -
Total Cost 35,209 40,584 52,302 51,438 74,759 52,702 148,008 -61.57%
Ratio Analysis
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
NP Margin -433.55 -303.58 -328.99 -138.75 26.26 -14.78 53.25 -
Per Share
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
EPS -0.10 -0.11 -0.14 -0.10 0.08 -0.02 0.54 -
EPS Diluted -0.10 -0.11 -0.14 -0.10 0.08 -0.02 0.54 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.